The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India

Background. The efficacy, safety, and cost benefit of olanzapine (OLN) when compared to aprepitant (APR) in the prevention of chemotherapy induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) were evaluated. Methods. A prospective pilot study was done in chem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chemother Res Pract
Main Authors: Babu, Govind, Saldanha, Smitha Carol, Kuntegowdanahalli Chinnagiriyappa, Lakshmaiah, Jacob, Linu Abraham, Mallekavu, Suresh Babu, Dasappa, Loknatha, Kiran, Pretesh Rohan, Sreevatsa, Aparna, Appachu, Sandhya, Unnikrishnan, Vineetha, Arroju, Venugopal
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748067/
https://ncbi.nlm.nih.gov/pubmed/26925265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/3439707
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados